1. Medtech Insight
  2. >>Policy & Regulation

FDA Clears J&J’s Ethicon Monarch Robotic System For Urology Procedures

 
• By Marion Webb

J&J’s entry into the kidney stone management market will not threaten Boston Scientific’s leadership position in that market in the near-term, according to Wells Fargo analyst Larry Biegelsen.

Kidney Stones
• Source: Shutterstock

Auris Health, Inc., a subsidiary of Johnson & Johnson Medtech’s Ethicon Inc. unit, announced on 2 May that its Monarch surgical robot received US Food and Drug Administration clearance for urology indications.

In particular, Monarch is cleared to help urologists reach and visualize areas within the kidney. (Also see "J&J To...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation